The price of false prophecy

'Many cancer trials in recent decades have measured the end joint (the outcome) in terms of additional months or years of life. Trialists have been very reluctant to measure the quality of the additional time.'

You need to be an HSJ subscriber to read more

HSJ

Subscribe to read the full article

With an HSJ subscription you’ll get access to:

  • Expert Briefing newsletters, covering nine topics and regions
  • Weekly Catch Up – a summary of the week’s most important stories
  • Unlimited access to hsj.co.uk
  • The HSJ app

Enquire about multi-user access